103.46
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Teleflex Incorporated stock is traded at $103.46, with a volume of 223.16K.
It is down -1.56% in the last 24 hours and down -15.41% over the past month.
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
See More
Previous Close:
$105.09
Open:
$104.91
24h Volume:
223.16K
Relative Volume:
0.30
Market Cap:
$4.57B
Revenue:
$3.04B
Net Income/Loss:
$191.94M
P/E Ratio:
24.36
EPS:
4.2479
Net Cash Flow:
$396.44M
1W Performance:
+0.44%
1M Performance:
-15.41%
6M Performance:
-11.76%
1Y Performance:
-42.76%
Teleflex Incorporated Stock (TFX) Company Profile
Name
Teleflex Incorporated
Sector
Industry
Phone
610-225-6800
Address
550 E SWEDESFORD RD, WAYNE, PA
Compare TFX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
TFX
Teleflex Incorporated
|
103.50 | 4.64B | 3.04B | 191.94M | 396.44M | 4.2479 |
|
ISRG
Intuitive Surgical Inc
|
527.14 | 186.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
200.11 | 58.70B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.14 | 39.80B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
45.64 | 38.25B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
251.63 | 37.27B | 5.26B | 1.44B | 1.76B | 9.7713 |
Teleflex Incorporated Stock (TFX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Downgrade | BofA Securities | Neutral → Underperform |
| Feb-28-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-28-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-28-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Feb-27-25 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| Jul-01-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-21-23 | Downgrade | Needham | Buy → Hold |
| May-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-26-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-26-22 | Initiated | Mizuho | Neutral |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-29-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-09-22 | Initiated | BofA Securities | Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Oct-07-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-07-21 | Resumed | Raymond James | Outperform |
| Jul-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jan-06-21 | Reiterated | Needham | Buy |
| Nov-02-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-31-20 | Reiterated | Needham | Buy |
| Aug-02-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Wells Fargo | Outperform |
| Apr-24-19 | Downgrade | Needham | Strong Buy → Buy |
| Feb-22-19 | Reiterated | Needham | Strong Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Sep-10-18 | Upgrade | Needham | Buy → Strong Buy |
| Aug-03-18 | Reiterated | Needham | Buy |
| May-14-18 | Reiterated | Needham | Buy |
| May-04-18 | Reiterated | Needham | Buy |
| Apr-04-18 | Initiated | Goldman | Neutral |
| Nov-10-17 | Resumed | Piper Jaffray | Overweight |
| Nov-03-17 | Reiterated | Needham | Buy |
| Sep-08-17 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
| Sep-06-17 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-06-17 | Reiterated | Needham | Buy |
| Mar-07-17 | Initiated | Needham | Buy |
| Jan-06-17 | Upgrade | Jefferies | Hold → Buy |
| Jul-12-16 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Teleflex Incorporated Stock (TFX) Latest News
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teleflex (TFX) and Biogen (BIIB) - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Investors to Connect - ACCESS Newswire
Teleflex Inc (TFX) Trading 3.01% Higher on Jan 22 - GuruFocus
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex IncorporatedTFX - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Teleflex stock hits 52-week low at 101.01 USD By Investing.com - Investing.com Canada
Teleflex (NYSE:TFX) Reaches New 12-Month LowWhat's Next? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Montagu and Kohlberg acquire Teleflex in $1.5bn carve out - Financier Worldwide
Teleflex stock hits 52-week low at 101.01 USD - Investing.com
Signal Recap: Is Teleflex Incorporated stock influenced by commodity pricesTrade Performance Summary & Community Trade Idea Sharing - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Stockholders to Connect - ACCESS Newswire
Synthetic Absorbable Sutures Market Size to Hit USD 4.36 Billion by 2033, Driven by Rising Surgical Volumes and Minimally Invasive Procedures – SNS Insider - GlobeNewswire Inc.
How geopolitical tensions affect Teleflex Incorporated stockMarket Volume Report & Daily Profit Maximizing Tips - bollywoodhelpline.com
Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Teleflex Incorporated stock a buy for dividend growth2025 Price Action Summary & Reliable Price Breakout Signals - bollywoodhelpline.com
Why Teleflex (TFX) Is Down 8.7% After CEO Exit, Lower 2025 Outlook And Legal Scrutiny - simplywall.st
Teleflex names new interim CEO - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Did Teleflex’s CEO Shake‑Up and Lowered 2025 Outlook Just Shift Its (TFX) Investment Narrative? - Yahoo Finance
Assessing Teleflex (TFX) Valuation After Recent Mixed Share Price Performance - Yahoo Finance
Teleflex strikes $2 billion asset sale, clears path for buybacks and focused growth - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex IncorporatedTFX - PR Newswire
Risk Off: Is Teleflex Incorporated stock technically oversoldJuly 2025 Action & Weekly Setup with ROI Potential - baoquankhu1.vn
Lobbying Update: $20,000 of TELEFLEX INCORPORATED lobbying was just disclosed - Quiver Quantitative
Gains Recap: What dividend safety score for Teleflex Incorporated stockTreasury Yields & Real-Time Volume Trigger Notifications - Bộ Nội Vụ
Will Teleflex Incorporated (TBH) stock sustain bullish trend into 2025Gap Up & Risk Managed Investment Signals - Улправда
Robeco Institutional Asset Management B.V. Raises Position in Teleflex Incorporated $TFX - MarketBeat
Is Teleflex Incorporated stock in buy zone after pullbackWeekly Market Outlook & Real-Time Volume Trigger Notifications - Улправда
Why retail investors favor Teleflex Incorporated stockJuly 2025 EndofMonth & Low Drawdown Investment Ideas - Улправда
Teleflex CEO leaving company - MedTech Dive
Teleflex Inc.: The Quiet Powerhouse Reinventing How Hospitals Touch the Human Body - AD HOC NEWS
Pulmonary Function Testing Market Size to Hit USD 5.66 Billion by 2033, Growing at a CAGR of 6.65% - GlobeNewswire Inc.
Is Teleflex’s (TFX) Interim CEO Shift And Softer 2025 Guide Reframing Its Execution Story? - simplywall.st
Could Cash Machine Teleflex Stock Be Your Next Buy? - Trefis
With Strong Cash Flow, Teleflex Stock Poised to Rise? - Trefis
Can Teleflex Stock Recover If Markets Fall? - Trefis
Teleflex Announces Leadership Transition - Sahm
Published on: 2026-01-09 08:22:51 - Улправда
What analyst consensus says on Teleflex Incorporated stockShare Buyback & Long-Term Safe Investment Plans - Улправда
How Teleflex Incorporated stock responds to policy changesTrade Exit Report & Technical Entry and Exit Tips - Улправда
Is Teleflex Incorporated stock a good choice for value investorsWeekly Stock Summary & Short-Term Swing Trade Alerts - ulpravda.ru
Teleflex Appoints Stuart Randle as Interim CEO - citybiz
Will Teleflex Incorporated stock outperform growth indexes2025 Historical Comparison & Community Consensus Stock Picks - ulpravda.ru
Teleflex (TFX) stock dives on CEO exit and revenue forecast cut — what investors watch next - TechStock²
Teleflex announces leadership transition as CEO Liam Kelly departs, cuts 2025 revenue guidance - MassDevice
Will Teleflex Incorporated stock benefit from Fed rate cutsDividend Hike & Free Safe Entry Trade Signal Reports - Улправда
Teleflex (NYSE:TFX) Shares Gap DownHere's Why - MarketBeat
Teleflex shares down 13.7% after lowering 2025 revenue forecast - marketscreener.com
Teleflex Has Leadership Change as CEO Liam Kelly Leaves, Lowers 2025 Revenue Guidance - Medical Product Outsourcing
Teleflex drops after lowering 2025 revenue forecast - TradingView — Track All Markets
Teleflex Incorporated Stock (TFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):